New report highlights innovations poised to drive significant
clinical and market impact
LONDON, May 22, 2024 /PRNewswire/ -- Clarivate
Plc (NYSE:CLVT), a leading global provider of transformative
intelligence, today announced the release of the Medical
Technologies to Watch in 2024 report. This first installment
of a two-part series offers a comprehensive predictive analysis of
high-growth medical technology markets poised to generate over
$1 billion in value or achieve
double-digit growth within the next five years.
The report underscores critical areas of significant investment.
Clarivate medtech analysts pinpoint five technologies driving
substantial clinical and commercial value in devices and
diagnostics this year. These innovations hold immense promise for
patients, potentially complementing or even supplanting traditional
medications and biochemical solutions.
April Chan-Tsui, Director,
Medtech Insights, Life Sciences & Healthcare, Clarivate
said: "Despite the challenges of the past five years, the
medtech industry has shown remarkable resilience, driving forward
with groundbreaking technological advancements. Backed by in-depth
industry expertise and robust data, this report highlights recent
breakthroughs poised to significantly improve patient outcomes.
These innovations represent the forefront of medtech's journey
towards extraordinary impact."
The Five 2024 Medical Technologies to Watch are:
- Pulsed field ablation devices
Pulsed field ablation (PFA) has emerged as a promising
treatment for atrial fibrillation (AF), garnering significant
attention from the cardiac ablation community. PFA employs electric
pulses, not heat, that help in the electroporation of the
myocardium without collateral damage to normal heart tissue.
Compared to established treatment options, PFA has remarkably low
recurrence rates, shorter treatment durations and higher success
rates.
- Diabetes care devices
Diabetes care technology is poised for significant growth
in the near future, driven by ongoing advancements. Beyond these
developments, significant activity is also underway in developing
alternative treatment options for diabetes management, including
new drug therapies and medical procedures that could potentially
impact the growth of the diabetes care technology market in the
coming years.
- Neurostimulation devices
The multibillion-dollar implantable neurostimulation device
market will grow as new and incumbent competitors expand treatable
indications and launch new devices with design and lifespan
improvements. The hypoglossal nerve stimulation device (HGNS)
market has, in particular, witnessed rapid growth, and it is
expected to surpass most other neurostimulation device markets in
size in upcoming years.
- Surgical robotics
Surgical robotic systems are revolutionizing the field of
medicine, offering better visualization, increased precision, and
better ergonomics for surgeons. These systems go beyond simple
robotic systems, providing a platform for minimally invasive
surgeries with benefits for both surgeons and patients. Despite
being considered innovative technology, robotics has become
increasingly common; in the orthopedics space, for example, all
major companies now offer a robotic system and have had to do so to
remain competitive against their leading peers.
- Renal denervation
The hypertension management market will regain its momentum
with the dawn of the long-awaited age of renal denervation (RDN)
technology. 2023 was eventful with the U.S. approvals of devices
from Recor Medical and Medtronic poised to impact the hypertension
management market in 2024 and beyond.
Exciting technologies are emerging in the medtech sector, but
the industry faces challenges including shifting service sites in
the critical U.S. market, global supply chain disruptions, the rise
of GLP-1 receptor agonists, the emergence of AI/ML, and the
fast-changing policy landscape. These challenges will be addressed
in part two of the Medtech Trends to Watch report.
Access the full Medical Technologies to Watch in 2024 report
from Clarivate, here.
For more Medical Technologies to Watch updates and analyses
throughout the year, visit the Medical Technologies to Watch web
page and follow Clarivate for Life Sciences & Healthcare on
LinkedIn and X. Join the conversation, using
#MedicalTechnologiesToWatch.
To learn more about how Clarivate can help medtech companies
evolve their commercialization strategies and answer new types of
business questions by obtaining actionable medtech insights across
the entire R&D lifecycle, visit here.
Methodology
To identify this year's Medical Technologies to Watch, Clarivate
drew from the expertise of over 40 analysts, covering over 80
medical device markets across more than 50 countries globally, and
integrated medtech intelligence datasets that span the R&D and
commercialization life cycle, along with other industry sources,
including company press releases, financial filings and
peer-reviewed publications. Clarivate proprietary data and
solutions used include Medtech 360, commercial targeting (Procedure
Finder/Healthbase), tracking tools (Marketrack/PriceTrack), and
Cortellis Competitive Intelligence™ and Cortellis Deals
Intelligence™ and other real world data analyses, including claims
data and government data analytics.
Clarivate analysts utilized our new Data Explorer application to
highlight markets that have a total forecast market value of more
than $1 billion or more by 2028 or
have rapid growth rates with high market values. Clarivate
experts and analysts evaluated each medical technology in its
individual context based on factors such as expected device
approval or launch dates, reimbursement potential, competitive
landscape, regulatory status, trial results, market dynamics and
other key factors.
About Clarivate
Clarivate™ is a leading global provider of transformative
intelligence. We offer enriched data, insights & analytics,
workflow solutions and expert services in the areas of Academia
& Government, Intellectual Property and Life Sciences &
Healthcare. For more information, please
visit www.clarivate.com
Media Contact:
Luna
Ivkovic
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com
Logo -
https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clarivate-identifies-five-breakthrough-medical-technologies-set-to-transform-patient-care-in-2024-302152188.html